Biotechnology & Pharmaceutical Services Outsourcing Market to Grow At a CAGR of 6.8% from 2021 to 2030

According to Report, the biotechnology & pharmaceutical services outsourcing market is expected to grow at a compound annual growth rate (CAGR) of 6.8% from 2021 to 2030 and to reach US$ 105.4 billion by 2030.

The high demand for biologics along with small molecules has led to the expansion of service portfolios of Contract Manufacturing Organizations (CMOs)/Contract Research Organizations (CROs) for biotechnology and pharmaceutical production. Small pharma/ biotech companies are facing challenges, such as lack of substantial expertise and expensive capability while performing in-house development, manufacturing, regulatory affairs, product maintenance, product design and development, product testing and validation, and training and education.

Get Free Sample Copy@ https://www.visionresearchreports.com/report/sample/38968

Report Coverage

Growth Factors

Rising pricing pressure, lack of internal capabilities, low-cost service offerings by CROs and CMOs, and access to industry experts are expected to drive the market over the forecast period. In addition, rising drug development costs, higher failure rates, and growing regulatory pressure have a significant impact on market dynamics, accelerating the growth rate. Furthermore, well-established Clinical Research Organizations (CROs), regulatory outsourcing firms, management consulting firms, and contract manufacturers are catering to the complex demand of the pharmaceutical and biotechnological sectors.

An increasing number of end-to-end service providers to meet the rising demand for low-cost drug development and manufacturing is further anticipated to propel the growth of the market. Moreover, novel drug delivery mechanisms and new product launches are anticipated to drive the outsourcing demand.

Key Players

• The Quantic Group
• IQVIA
• Parexel International Corporation
• Lachman Consultant Services, Inc.
• GMP Pharmaceuticals Pty Ltd.
• Concept Heidelberg GmbH
• Covance Inc.
• Charles River Laboratories
• PRA Health Sciences
• ICON plc

Market Segmentation

• By Service
  • Consulting
    • Regulatory Compliance
    • Remediation
    • Quality Management Systems Consulting
    • Others
  • Auditing and Assessment
  • Regulatory Affairs
    • Clinical Trial Applications & Product Registration
    • Regulatory Writing & Publishing
    • Legal Representation
    • Others
  • Product Maintenance
  • Product Design & Development
  • Product Testing & Validation
  • Training & Education
  • Others
• By End-use
  • Pharma
  • Biotech
• Regional
  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
  • Asia Pacific
    • India
    • China
    • Japan
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/38968

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

The study objectives of this report are:

• To analyze and study the global market capacity, production, value, consumption, status (2017-2020) and forecast (2021-2030);
• Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
• Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
• To define, describe and forecast the market by type, application and region.
• To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
• To identify significant trends and factors driving or inhibiting the market growth.
• To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
• To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
• To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and End-use Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Biotechnology & Pharmaceutical Services Outsourcing Market, By Service

7.1.  Biotechnology & Pharmaceutical Services Outsourcing Market, by Service, 2021-2030

7.1.1.    Consulting

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Auditing and Assessment

7.1.2.1.        Market Revenue and Forecast (2017-2030)

7.1.3.    Regulatory Affairs

7.1.3.1.        Market Revenue and Forecast (2017-2030)

7.1.4.    Product Maintenance

7.1.4.1.        Market Revenue and Forecast (2017-2030)

7.1.5.    Product Design & Development

7.1.5.1.        Market Revenue and Forecast (2017-2030)

7.1.6.    Product Testing & Validation

7.1.6.1.        Market Revenue and Forecast (2017-2030)

7.1.7.    Training & Education

7.1.7.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Biotechnology & Pharmaceutical Services Outsourcing Market, By End-use

8.1.  Biotechnology & Pharmaceutical Services Outsourcing Market, by End-use, 2021-2030

8.1.1.    Pharma

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Biotech

8.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global Biotechnology & Pharmaceutical Services Outsourcing Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.    Market Revenue and Forecast, by Service (2017-2030)

9.1.2.    Market Revenue and Forecast, by End-use (2017-2030)

9.1.3.    U.S.

9.1.3.1.        Market Revenue and Forecast, by Service (2017-2030)

9.1.3.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.1.4.    Rest of North America

9.1.4.1.        Market Revenue and Forecast, by Service (2017-2030)

9.1.4.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.2.  Europe

9.2.1.    Market Revenue and Forecast, by Service (2017-2030)

9.2.2.    Market Revenue and Forecast, by End-use (2017-2030)

9.2.3.    UK

9.2.3.1.        Market Revenue and Forecast, by Service (2017-2030)

9.2.3.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.2.4.    Germany

9.2.4.1.        Market Revenue and Forecast, by Service (2017-2030)

9.2.4.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.2.5.    France

9.2.5.1.        Market Revenue and Forecast, by Service (2017-2030)

9.2.5.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.2.6.    Rest of Europe

9.2.6.1.        Market Revenue and Forecast, by Service (2017-2030)

9.2.6.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.3.  APAC

9.3.1.    Market Revenue and Forecast, by Service (2017-2030)

9.3.2.    Market Revenue and Forecast, by End-use (2017-2030)

9.3.3.    India

9.3.3.1.        Market Revenue and Forecast, by Service (2017-2030)

9.3.3.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.3.4.    China

9.3.4.1.        Market Revenue and Forecast, by Service (2017-2030)

9.3.4.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.3.5.    Japan

9.3.5.1.        Market Revenue and Forecast, by Service (2017-2030)

9.3.5.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.3.6.    Rest of APAC

9.3.6.1.        Market Revenue and Forecast, by Service (2017-2030)

9.3.6.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.4.  MEA

9.4.1.    Market Revenue and Forecast, by Service (2017-2030)

9.4.2.    Market Revenue and Forecast, by End-use (2017-2030)

9.4.3.    GCC

9.4.3.1.        Market Revenue and Forecast, by Service (2017-2030)

9.4.3.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.4.4.    North Africa

9.4.4.1.        Market Revenue and Forecast, by Service (2017-2030)

9.4.4.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.4.5.    South Africa

9.4.5.1.        Market Revenue and Forecast, by Service (2017-2030)

9.4.5.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.4.6.    Rest of MEA

9.4.6.1.        Market Revenue and Forecast, by Service (2017-2030)

9.4.6.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.5.  Latin America

9.5.1.    Market Revenue and Forecast, by Service (2017-2030)

9.5.2.    Market Revenue and Forecast, by End-use (2017-2030)

9.5.3.    Brazil

9.5.3.1.        Market Revenue and Forecast, by Service (2017-2030)

9.5.3.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.5.4.    Rest of LATAM

9.5.4.1.        Market Revenue and Forecast, by Service (2017-2030)

9.5.4.2.        Market Revenue and Forecast, by End-use (2017-2030)

Chapter 10.  Company Profiles

10.1.              The Quantic Group

10.1.1.  Company Overview

10.1.2.  Service Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.              IQVIA

10.2.1.  Company Overview

10.2.2.  Service Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.              Parexel International Corporation

10.3.1.  Company Overview

10.3.2.  Service Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.              Lachman Consultant Services, Inc.

10.4.1.  Company Overview

10.4.2.  Service Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.              GMP Pharmaceuticals Pty Ltd.

10.5.1.  Company Overview

10.5.2.  Service Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

10.6.              Concept Heidelberg GmbH

10.6.1.  Company Overview

10.6.2.  Service Offerings

10.6.3.  Financial Performance

10.6.4.  Recent Initiatives

10.7.              Covance Inc.

10.7.1.  Company Overview

10.7.2.  Service Offerings

10.7.3.  Financial Performance

10.7.4.  Recent Initiatives

10.8.              Richard Wolf GmbH

10.8.1.  Company Overview

10.8.2.  Service Offerings

10.8.3.  Financial Performance

10.8.4.  Recent Initiatives

10.9.              Charles River Laboratories

10.9.1.  Company Overview

10.9.2.  Service Offerings

10.9.3.  Financial Performance

10.9.4.  Recent Initiatives

10.10.           PRA Health Sciences

10.10.1.               Company Overview

10.10.2.               Service Offerings

10.10.3.               Financial Performance

10.10.4.               Recent Initiatives

Chapter 11.  Research Methodology

11.1.              Primary Research

11.2.              Secondary Research

11.3.              Assumptions

Chapter 12.  Appendix

12.1.              About Us

12.2.              Glossary of Terms

Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/38968

About Us: Our team of skilled and experienced analysts specializes in troubleshooting problems faced by our clients. For comprehensive summary of our services and market research requirements for Global industry.

Contact Us:

call: +1 9197 992 333

Vision Research Report

Any Assistance, Email – sales@visionresearchreports.com